These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32717689)

  • 1. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM; Gad-Elkareem MAM; Hassane Anouar E; Aouadi K; Kadri A; Snoussi M
    Bioorg Chem; 2020 Sep; 102():104105. PubMed ID: 32717689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New polyfunctional imidazo[4,5-C]pyridine motifs: synthesis, crystal studies, docking studies and antimicrobial evaluation.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Jasinski JP; Millikan SP; Chandrika N; More SS; Harish BG
    Eur J Med Chem; 2014 Apr; 77():288-97. PubMed ID: 24657565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
    Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
    Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs.
    Al-Tel TH; Al-Qawasmeh RA; Zaarour R
    Eur J Med Chem; 2011 May; 46(5):1874-81. PubMed ID: 21414694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, antimicrobial, antiquorum-sensing and antitumor evaluation of new series of pyrazolopyridine derivatives.
    El-Gohary NS; Shaaban MI
    Eur J Med Chem; 2018 Sep; 157():729-742. PubMed ID: 30138804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Wang XD; Deng RC; Dong JJ; Peng ZY; Gao XM; Li ST; Lin WQ; Lu CL; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2013 Sep; 21(17):4914-22. PubMed ID: 23891164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New substituted pyrazolones and dipyrazolotriazines as promising tyrosyl-tRNA synthetase and peroxiredoxin-5 inhibitors: Design, synthesis, molecular docking and structure-activity relationship (SAR) analysis.
    Othman IMM; Gad-Elkareem MAM; Hassane Anouar E; Aouadi K; Snoussi M; Kadri A
    Bioorg Chem; 2021 Apr; 109():104704. PubMed ID: 33609915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
    Li QS; Ni HJ; Yang Y; Lv XH; Ruan BF
    Med Chem; 2015; 11(3):305-13. PubMed ID: 25219926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
    Guo ZH; Yin Y; Wang C; Wang PF; Zhang XT; Wang ZC; Zhu HL
    Bioorg Med Chem; 2015 Sep; 23(18):6148-56. PubMed ID: 26304108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, structure elucidation, antimicrobial, molecular docking, and SAR studies of novel urea derivatives bearing tricyclic aromatic hydrocarbon rings.
    Sroor FM; El-Sayed AF; Abdelraof M
    Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300738. PubMed ID: 38466125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2-c]pyridine Mannich bases.
    Jose G; Suresha Kumara TH; Sowmya HBV; Sriram D; Guru Row TN; Hosamani AA; More SS; Janardhan B; Harish BG; Telkar S; Ravikumar YS
    Eur J Med Chem; 2017 May; 131():275-288. PubMed ID: 28340368
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Monobe K; Taniguchi H; Aoki S
    Curr Comput Aided Drug Des; 2024; 20(5):452-462. PubMed ID: 37309761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
    Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
    Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
    Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure elucidation, Hirshfeld surface analysis, DFT, and molecular docking of new 6-bromo-imidazo[4,5-
    Jabri Z; Thiruvalluvar AA; Sghyar R; Mague JT; Sabir S; Rodi YK; Anouar EH; Misbahi K; Sebbar NK; Essassi EM
    J Biomol Struct Dyn; 2023; 41(21):12347-12362. PubMed ID: 36744539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
    Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP; Wei W; Wang PF; Shi WK; Zhu N; Xie MQ; Sun YW; Li LX; Xie YX; Zhu LS; Tang N; Ouyang H; Li XH; Wang GC; Zhu HL
    Eur J Med Chem; 2015 Sep; 102():631-8. PubMed ID: 26318069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
    Chen LW; Wang PF; Tang DJ; Tao XX; Man RJ; Qiu HY; Wang ZC; Xu C; Zhu HL
    Chem Biol Drug Des; 2016 Oct; 88(4):592-8. PubMed ID: 27206529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.